51�Թ�

A good example concerned the drug company Biogen, which paid $900 million to the federal and state governments in 2022 to settle a qui tam lawsuit in which a former employee alleged that the company had paid kickbacks to doctors to entice them to prescribe its multiple sclerosis drugs.

Eisai, a Japanese drugmaker that has partnered with Biogen, is promoting Leqembi to doctors and people concerned about their memories.

Already, Roche, Pfizer, Merck, Biogen, and other industry giants have formed early partnerships with quantum computing companies, hoping the new technology will accelerate discovery.

The announcement came a week after drugmakers Biogen and Ionis Pharmaceuticals said they are terminating development of BIIB105, an antisense oligonucleotide for ALS that showed disappointing results in an early-stage clinical study.

In January, its distributor, Biogen, abandoned the drug to pursue other possible treatments.